Rujuta A. Bam

1.2k total citations
11 papers, 609 citations indexed

About

Rujuta A. Bam is a scholar working on Infectious Diseases, Virology and Oncology. According to data from OpenAlex, Rujuta A. Bam has authored 11 papers receiving a total of 609 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 4 papers in Virology and 3 papers in Oncology. Recurrent topics in Rujuta A. Bam's work include HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Rujuta A. Bam is often cited by papers focused on HIV/AIDS drug development and treatment (7 papers), HIV Research and Treatment (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Rujuta A. Bam collaborates with scholars based in United States, Germany and Portugal. Rujuta A. Bam's co-authors include Tomáš Cihlář, Stephen R. Yant, Kirsten M. Stray, Luong Tsai, Anita Niedziela‐Majka, Gabriel Birkuš, Andrew Mulato, Derek Hansen, G.S. Jones and Christian Frey and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Protein Engineering Design and Selection.

In The Last Decade

Rujuta A. Bam

11 papers receiving 602 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rujuta A. Bam United States 8 471 379 141 135 92 11 609
Roberta Amici Italy 13 341 0.7× 275 0.7× 83 0.6× 162 1.2× 81 0.9× 46 534
Akil Jackson United Kingdom 20 686 1.5× 525 1.4× 79 0.6× 197 1.5× 228 2.5× 52 888
Kabamba Kabeya Belgium 12 438 0.9× 397 1.0× 101 0.7× 135 1.0× 56 0.6× 23 638
Elizabeth Gould United States 12 540 1.1× 387 1.0× 83 0.6× 169 1.3× 57 0.6× 15 719
Lorant Leopold United States 9 500 1.1× 347 0.9× 86 0.6× 258 1.9× 54 0.6× 14 663
Dan Duiculescu Romania 11 805 1.7× 628 1.7× 92 0.7× 225 1.7× 219 2.4× 22 949
Romina Quercia United Kingdom 10 408 0.9× 335 0.9× 66 0.5× 75 0.6× 114 1.2× 16 491
Lucinda R. Gilde United States 3 573 1.2× 513 1.4× 137 1.0× 57 0.4× 78 0.8× 3 627
Brett S. Robinson United States 6 445 0.9× 424 1.1× 169 1.2× 57 0.4× 39 0.4× 9 633
Alex Dusek United States 5 324 0.7× 302 0.8× 58 0.4× 66 0.5× 31 0.3× 7 399

Countries citing papers authored by Rujuta A. Bam

Since Specialization
Citations

This map shows the geographic impact of Rujuta A. Bam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rujuta A. Bam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rujuta A. Bam more than expected).

Fields of papers citing papers by Rujuta A. Bam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rujuta A. Bam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rujuta A. Bam. The network helps show where Rujuta A. Bam may publish in the future.

Co-authorship network of co-authors of Rujuta A. Bam

This figure shows the co-authorship network connecting the top 25 collaborators of Rujuta A. Bam. A scholar is included among the top collaborators of Rujuta A. Bam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rujuta A. Bam. Rujuta A. Bam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Bennett, Dimitri, Fátima Roque, Rujuta A. Bam, et al.. (2023). Long-COVID-19 clinical and health outcomes: an umbrella review. Therapeutic Advances in Infectious Disease. 10. 2018433151–2018433151. 5 indexed citations
2.
Wohl, David A., et al.. (2022). COVID-19 therapies for inpatients: a review and quality assessment of clinical guidelines. ERJ Open Research. 8(4). 236–2022. 2 indexed citations
3.
Karrer, Erik E., Madan Paidhungat, Margaret Neighbors, et al.. (2016). ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution. Protein Engineering Design and Selection. 29(5). 159–167. 7 indexed citations
4.
Bam, Rujuta A., Derek Hansen, Alivelu Irrinki, et al.. (2016). TLR7 Agonist GS-9620 Is a Potent Inhibitor of Acute HIV-1 Infection in Human Peripheral Blood Mononuclear Cells. Antimicrobial Agents and Chemotherapy. 61(1). 49 indexed citations
5.
Tsiang, Manuel, G.S. Jones, Joshua Goldsmith, et al.. (2016). Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile. Antimicrobial Agents and Chemotherapy. 60(12). 7086–7097. 219 indexed citations
6.
Birkuš, Gabriel, Rujuta A. Bam, Madeleine Willkom, et al.. (2015). Intracellular Activation of Tenofovir Alafenamide and the Effect of Viral and Host Protease Inhibitors. Antimicrobial Agents and Chemotherapy. 60(1). 316–322. 61 indexed citations
7.
Dahlin, Amber, Matthias Wittwer, Melanie de la Cruz, et al.. (2014). A pharmacogenetic candidate gene study of tenofovir-associated Fanconi syndrome. Pharmacogenetics and Genomics. 25(2). 82–92. 23 indexed citations
8.
Stray, Kirsten M., Rujuta A. Bam, Gabriel Birkuš, et al.. (2013). Evaluation of the Effect of Cobicistat on theIn VitroRenal Transport and Cytotoxicity Potential of Tenofovir. Antimicrobial Agents and Chemotherapy. 57(10). 4982–4989. 39 indexed citations
9.
Balakrishnan, M., Stephen R. Yant, Luong Tsai, et al.. (2013). Non-Catalytic Site HIV-1 Integrase Inhibitors Disrupt Core Maturation and Induce a Reverse Transcription Block in Target Cells. PLoS ONE. 8(9). e74163–e74163. 96 indexed citations
10.
Bam, Rujuta A., Stephen R. Yant, & Tomáš Cihlář. (2013). Tenofovir Alafenamide is Not a Substrate for Renal Organic Anion Transporters (Oats) and Does Not Exhibit Oat-Dependent Cytotoxicity. Antiviral Therapy. 19(7). 687–692. 77 indexed citations
11.
Bam, Rujuta A., Gabriel Birkuš, Darius Babusis, Tomáš Cihlář, & Stephen R. Yant. (2013). Metabolism and Antiretroviral Activity of Tenofovir Alafenamide in CD4+ T-Cells and Macrophages from Demographically Diverse Donors. Antiviral Therapy. 19(7). 669–677. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roberta Amici Breakdown of academic impact, for papers by Akil Jackson Breakdown of academic impact, for papers by Kabamba Kabeya Breakdown of academic impact, for papers by Elizabeth Gould Breakdown of academic impact, for papers by Lorant Leopold Breakdown of academic impact, for papers by Dan Duiculescu Breakdown of academic impact, for papers by Romina Quercia Breakdown of academic impact, for papers by Lucinda R. Gilde Breakdown of academic impact, for papers by Brett S. Robinson Breakdown of academic impact, for papers by Alex Dusek
Rankless by CCL
2026